Intravenous milrinone infusion improves congestive heart failure caused by diastolic dysfunction: A brief case series

Texas Heart Institute Journal

Volumn 32, Issue 2, 2005, Pages 220-223

  Albrecht, Carlos A ^a   Giesler, Gregory M ^a   Kar, Biswajit ^a   Hariharan, Ramesh ^a   Delgado III, Reynolds M ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b TEXAS HEART INSTITUTE   (United States)

Author keywords

Diastole drug effects; Heart failure, congestive therapy; Humans; Infusions, intravenous; Milrinone therapeutic use; Myocardial contraction; Stroke volume; Ventricular dysfunction, left

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MILRINONE; PREDNISONE;

ADULT; AGED; ARTICLE; CASE REPORT; CONGESTIVE HEART FAILURE; DIASTOLIC BLOOD PRESSURE; DRUG INFUSION; ECHOCARDIOGRAPHY; HEART FUNCTION; HUMAN; LONG TERM CARE; MALE; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; CARDIOTONIC AGENTS; DIASTOLE; ECHOCARDIOGRAPHY; HEART FAILURE, CONGESTIVE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MILRINONE; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 20444398520     PISSN: 07302347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Chen EP, Craig DM, Bittner HB, Davis RD, Van Trigt P. Pharmacological strategies for improving diastolic dysfunction in the setting of chronic pulmonary hypertension. Circulation 1998;97:1606-12.
2. Dauterman KW, Massie BM, Gheorghiade M. Heart failure associated with preserved systolic function: a common and costly clinical entity. Am Heart J 1998;135(6 Pt 2 Su): S310-9.
3. Senni M, Tribouilloy CM, Rodeheffer RJ, Jacobsen SJ, Evans JM, Bailey KR, Redfield MM. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 1998;98:2282-9.
4. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999;33:1948-55.
5. Kitzman DW, Gardin JM, Gottdiener JS, Arnold A, Boineau R, Aurigemma G, et al. Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol 2001;87:413-9.
6. Monrad ES, McKay RG, Baim DS, Colucci WS, Fifer MA, Heller GV, et al. Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone. Circulation 1984;70:1030-7.
7. Tanaka H, Tajimi K, Matsumoto A, Kobayashi K. Vasodilatory effects of milrinone on pulmonary vasculature in dogs with pulmonary hypertension due to pulmonary embolism: a comparison with those of dopamine and dobutamine. Clin Exp Pharmacol Physiol 1990;17:681-90.
8. Honerjager P. Pharmacology of bipyridine phosphodiesterase III inhibitors. Am Heart J 1991;121(6 Pt 2):1939-44.
9. Chen HH, Lainchbury JG, Senni M, Bailey KR, Redfield MM. Diastolic heart failure in the community: clinical profile, natural history, therapy, and impact of proposed diagnostic criteria. J Card Fail 2002;8:279-87.
10. Zile MR, Gaasch WH, Carroll JD, Feldman MD, Aurigemma GP, Schaer GL, et al. Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation 2001;104:779-82.
11. Felker GM, O'Connor CM. Inotropic therapy for heart failure: an evidence-based approach. Am Heart J 2001;142:393-401.
12. Zewail AM, Nawar M, Vrtovec B, Eastwood C, Kar MN, Delgado RM 3rd. Intravenous milrinone in treatment of advanced congestive heart failure. Tex Heart Inst J 2003;30:109-13.
13. Soufer R, Wohlgelernter D, Vita NA, Amuchestegui M, Sostman HD, Berger HJ, Zaret BL. Intact systolic left ventricular function in clinical congestive heart failure. Am J Cardiol 1985;55:1032-6.
14. Heo J, Iskandrian AS, Hakki AH. Relation between left ventricular diastolic function and exercise tolerance in patients with left ventricular dysfunction. Cathet Cardiovasc Diagn 1986;12:311-6.
15. Lucas C, Johnson W, Hamilton MA, Fonarow GC, Woo MA, Flavell CM, et al. Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am Heart J 2000;140:840-7.
16. Grossman W. Diastolic dysfunction and congestive heart failure. Circulation 1990;81(2 Suppl):III1-7.
17. Krams R, McFalls E, van der Giessen WJ, Serruys PW, Verdoun PD, Roelandt J. Does intravenous milrinone have a direct effect on diastolic function? Am Heart J 1991;121(6 Pt2):1951-5.